Rain Therapeutics Inc. (RAIN) is a publicly traded company in the Unknown sector. Across all available filings, 23 corporate insiders have executed 133 transactions totaling $127.2M, demonstrating a bullish sentiment with $122.8M in net insider flow. The most recent transaction on Sep 12, 2025 involved a sale of 4,787 shares valued at $27.7K.
No significant insider buying has been recorded for RAIN in the recent period.
No significant insider selling has been recorded for RAIN in the recent period.
Based on recent SEC filings, insider sentiment for RAIN is bullish with an Insider Alignment Score of 98/100 and a net flow of $122.8M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Rain Therapeutics Inc. (RAIN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 23 insiders are actively trading RAIN stock, having executed 133 transactions in the past 90 days. The most active insider is Gp Holdings Llc Bvf (Executive), who has made 15 transactions totaling $25.7M.
Get notified when executives and directors at RAIN file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Sep 12, 2025 | B. Dickerson Lyman | Executive | Sale | 4,787 | $5.78 | $27.7K | |
| Sep 11, 2025 | B. Dickerson Lyman | Executive | Sale | 398 | $5.80 | $2.3K | |
| Sep 10, 2025 | B. Dickerson Lyman | Executive | Sale | 215 | $5.55 | $1.2K | |
| Sep 9, 2025 | B. Dickerson Lyman | Executive | Sale | 1,917 | $5.24 | $10.0K | |
| Sep 5, 2025 | Seidl Randy | Executive | Award | 602,320 | $N/A | $0 | |
| Jan 26, 2024 | Vellanki Avanish | Executive | Tender | 2,550,910 | $N/A | $0 | |
| Jan 26, 2024 | Doebele Robert | Executive | Tender | 476,827 | $N/A | $0 | |
| Jan 26, 2024 | M. Berger Franklin | Executive | Tender | 1,005,207 | $N/A | $0 | |
| Jan 26, 2024 | I. Davis Aaron | Executive | Tender | 79,726 | $N/A | $0 | |
| Jan 26, 2024 | Radovich Peter | Executive | Tender | 8,796 | $N/A | $0 | |
| Jan 26, 2024 | Partners Lp Tang Capital | Executive | Tender | 3,850,513 | $N/A | $0 | |
| Jan 25, 2024 | Fund II Lp Biotechnology Value | Executive | Tender | 185,388 | $N/A | $0 | |
| Jan 25, 2024 | Fund II Lp Biotechnology Value | Executive | Tender | 341,547 | $N/A | $0 | |
| Jan 25, 2024 | Fund II Lp Biotechnology Value | Executive | Tender | 1,734,960 | $N/A | $0 | |
| Jan 25, 2024 | Fund II Lp Biotechnology Value | Executive | Tender | 2,076,085 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 73 | $125.0M | 85.4% |
Award(A) | 10 | $19.1M | 13.1% |
Sale(S) | 15 | $2.2M | 1.5% |
Exercise(M) | 4 | $93.0K | 0.1% |
Tender(U) | 12 | $0 | 0.0% |
Gift(G) | 2 | $0 | 0.0% |
Conversion(C) | 17 | $0 | 0.0% |
Insiders at Rain Therapeutics Inc. are accumulating shares at an accelerated pace. With 23 insiders making 133 transactions totaling $125.0M in purchases versus $2.2M in sales, the net buying activity of $122.8M signals strong executive confidence. Gp Holdings Llc Bvf (Executive) leads the buying activity with $25.7M in transactions across all time.